Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload

American Heart Journal

Volumn 138, Issue 4 I, 1999, Pages 641-645

  Nanbu, T ^a   Nakakoshi, T ^a   Yonezawa, K ^a   Kitabatake, A ^a  

^a Date Red Cross Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; DOBUTAMINE; PHOSPHATE; PHOSPHORUS 31;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICLE SIZE; HUMAN; MALE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; WORKLOAD;

EID: 0032888606     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70177-8     Document Type: Article

References (19)

1. 13C NMR. J Magn Reson Imaging 1984;59:338-42.
2. Schaefer S, Gober J, Valenza M, Karczmar GS, Matson GB, Camacho SA, et al. Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol 1988;12:1449-55.
3. Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med 1990;14:425-34.
4. 31P Magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-8.
5. Willens HJ, Blevins RD, Wrisley D, Antonishen D, Reinstein D, Rubenfire M. The prognostic value of functional capacity in patients with mild to moderate heart failure. Am Heart J 1987; 114:377-82.
6. Schaefer S, Schwartz GG, Steinman SK, Meyerhoff DJ, Massie BM, Weiner MW. Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus-31 studies of normal and cardiomyopathic myocardium. Magn Reson Med 1992;25:260-72.
7. Sauter R, Schneider M, Wicklow K, Kolem H. Current status of clinically relevant techniques in magnetic resonance spectroscopy. Electromedia 1992;60:32-54.
8. Quinones MA, Gaasch WH, Alexander JK. Echocardiographic assessment of left ventricular function. Circulation 1974;50:42-51.
9. Paraskos JA, Grossman W, Saltz S, Dalen JE, Dexter L. A noninvasive technique for the determination of velocity of circumferential fiber shortening in man. Circulation 1971;29:610-5.
10. Pool PE, Spann JF Jr, Buccino RA, Sonnenblick EH, Braunwald E. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure. Circ Res 1967;21:365-73.
11. Ingwall JS. On the hypothesis: cardiac failure is due to decreased energy reserve. Circulation 1993;87(suppl VII):VII-58-VII-62.
12. Tian R, Nascimben L, Daouk R, Ingwall JS. Depletion of energy reserve via creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol 1996;28:755-65.
13. Takahashi M, Shichiri G, Amano M, Kanamori T, Kinoshita M. Increased uncoupling of b-, b1- and b2-adrenoceptor to myocardial contraction in failing human myocardium. Jpn Circ J 1992;56:701-9.
14. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Physiology of exercise. Princeple of exercise testing and interpretation. Philadelphia: Lea & Febiger; 1987. p. 17-20.
15. Jewitt DE, Birkhead J, Mitchell A, Dollery C. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic cathecolamine. Lancet 1974;2:363-7.
16. Sonnenblick EH, Frishman WH, LeJemtel TH. Dobutamine: a new synthetic cardioselective sympathetic amine. N Engl J Med 1979; 300:17-22.
17. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation 1978; 58:466-75.
18. Francis G, Sharma B, Hodges M. Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 1982;103:995-1000.
19. Krell MJ, Kline EM, Bates ER, Hodgson JM, Dilworth LR, Laufer N, et al. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 1986;112:787-91.